Mayne Pharma’s new battle | Ray-Ban smart glasses are all the rage | Nestlé cuts 16,000 jobs

2025-10-19

ASX-listed Mayne Pharma saw its shares spike 14% after a court ruled that its acquirer cannot terminate its $672 million acquisition offer Ray-Ban maker EssilorLuxottica just hit record sales as smart glasses go from nerdy to need one now Nestlé’s new CEO is cutting 16,000 jobs as it looks to trim costs while also speeding up growth _ Download the free app (App Store): http://bit.ly/FluxAppStore Download the free app (Google Play): http://bit.ly/FluxappGooglePlay Daily newsletter: ht...

ASX-listed Mayne Pharma saw its shares spike 14% after a court ruled that its acquirer cannot terminate its $672 million acquisition offer

Ray-Ban maker EssilorLuxottica just hit record sales as smart glasses go from nerdy to need one now

Nestlé’s new CEO is cutting 16,000 jobs as it looks to trim costs while also speeding up growth

Download the free app (App Store): http://bit.ly/FluxAppStore

Download the free app (Google Play): http://bit.ly/FluxappGooglePlay

Daily newsletter: https://bit.ly/fluxnewsletter

Flux on Instagram: http://bit.ly/fluxinsta

Flux on TikTok: https://www.tiktok.com/@flux.finance

—-

The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.
__

See omnystudio.com/listener for privacy information.

Comments (3)